Home > SOP Information > SOPs and Supporting Information – alphabetic listing > M > Malignant Neoplasm of the Endometrium B045

Malignant Neoplasm of the Endometrium B045

Last amended 
Thursday, March 17, 2016

Current RMA Instruments:

Reasonable Hypothesis SOP [1]
11 of 2016
Balance of Probabilities SOP [2]
12 of 2016
Changes from previous Instruments:

SOP Bulletin 188 [3]

 ICD Coding:
  • ICD-9-CM Codes: 182.0
  • ICD-10-AM Codes: C54.1
Brief description

This SOP covers cancer of the lining of the uterus.

Confirming the diagnosis

Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.

The relevant medical specialist is a gynaecologist or gynaecological oncologist.

Diagnoses covered by SOP
  • Adenoacanthoma of the endometrium
  • Adenocarcinoma of the endometrium
  • Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
  • Carcinoma-in-situ of the endometrium
  • Carcinosarcoma of the endometrium
  • Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
  • Hodgkin's lymphoma of the endometrium*
  • Leiomyoma (fibroid) of the uterus#
  • Malignant neoplasm of the cervix*
  • non-Hodgkin's lymphoma of the endometrium*
  • soft tissue sarcoma of the endometrium*

 *another SOP applies, # nonSOP

Clinical onset

Clinical onset will be when the condition was first diagnosed.  It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.

Clinical worsening

The SOP has only an inability to obtain apropriate clinical management factor for worsening.  Timely treatment can alter the course of the condition.  Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.

 

Rulebase for malignant neoplasm of the endometrium

Place holder node for Rulebase for malignant neoplasm of the endometrium

A course of therapeutic radiation involving the pelvic organs

Malignant neoplasm of the endometrium - A course of therapeutic radiation involving the pelvic organs Factor

Last reviewed for CCPS 30 April 1997.

Preliminary questions [14042]

16834 [5] there is some evidence that therapeutic radiation involving the pelvic organs may be a factor in the development of the condition under consideration.

1169 — the veteran is a woman. [6]

[5]14062

the veteran has had a course of therapeutic radiation involving the pelvic organs at some time.

14063 [7] the course of therapeutic radiation involving the pelvic organs was given for treatment of an illness or injury which is identifiable.

[8]14064

the veteran received the course of therapeutic radiation to the pelvic organs for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium. [9]

14065 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14066 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14067 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14066]

14068 — the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given is causally related to operational service. [10] [11]

Clinical onset and eligible service [14067]

14069 — the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given is causally related to eligible service. [12] [11]

Being nulliparous

Malignant neoplasm of the endometrium - Being nulliparous Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Medical Report - Being Nulliparous - Malignant Neoplasm of the Endometrium [MR9085]

Preliminary questions [14038]

[13]29106

there is some evidence that being nulliparous may be a factor in the development of the condition under consideration.

1169 — the veteran is a woman. [6]

[14]14095

the veteran was nulliparous immediately before the clinical onset of the condition under consideration.

[15]14096

the veteran's nulliparous state immediately before the clinical onset of the condition under consideration was substantially attributable to the taking of oral contraceptives containing oestrogen and progestogen.

[16]14097

the veteran was nulliparous immediately before the clinical onset of the condition under consideration because of an illness or injury which is identifiable. [17]

14098 — the veteran has established the causal connection between being nulliparous and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14099 — the veteran has established the causal connection between being nulliparous and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14100 — the veteran has established the causal connection between being nulliparous and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14099]

8870 — the identified illness or injury which caused the veteran to be nulliparous is causally related to operational service. [18] [19]

Clinical onset and eligible service [14100]

14101 — the identified illness or injury which caused the veteran to be nulliparous is causally related to eligible service. [20] [19]

Hormonal replacement therapy

Malignant neoplasm of the endometrium - Hormonal replacement therapy Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Medical Report - Hormone Replacement Medication - Malignant Neoplasm of the Endometrium [MR9086]

Preliminary questions [14041]

1169 — the veteran is a woman. [21] [22]

[23]9172

the veteran has had a course of hormone replacement therapy at some time.

8813 [24] the veteran has undergone a course of hormone replacement medication consisting of oestrogen unopposed by progesterone at some time.

[25]8814

the course of hormone replacement medication consisting of oestrogen unopposed by progesterone was undergone for treatment of an illness or injury which is identifiable.

[26]14102

the veteran underwent the course of hormone replacement medication consisting of oestrogen unopposed by progesterone for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium. [27]

14103 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14104 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14105 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14104]

8823 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service. [28] [29]

Clinical onset and eligible service [14105]

8824 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service. [30] [29]

No appropriate clinical management for malignant neoplasm of endometrium

Malignant neoplasm of the endometrium - No appropriate clinical management for malignant neoplasm of endometrium Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Medical Report - Inability to Obtain Appropriate Clinical Management - [GQACM]

Preliminary questions [14044]

[31]14076

there is some evidence that an inability to obtain appropriate clinical management for malignant neoplasm of the endometrium may be a factor in the worsening of the condition under consideration.

1169 — the veteran is a woman. [6]

[32]14077

the clinical onset of malignant neoplasm of the endometrium occurred after the end of the veteran's last period of VEA service.

[33]14078

the veteran's malignant neoplasm of the endometrium permanently worsened.

[34]14079

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium at some time.

14080 [35] an inability to obtain appropriate clinical management for malignant neoplasm of the endometrium contributed to the clinical worsening of the veteran's malignant neoplasm of the endometrium.

14082 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and VEA service for the clinical worsening of malignant neoplasm of the endometrium.

14083 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and operational service for the clinical worsening of malignant neoplasm of the endometrium.

or

14084 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and eligible service for the clinical worsening of malignant neoplasm of the endometrium.

Clinical worsening and operational service [14083]

[36]14085

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium during operational service.

[37]16632

the veteran was unable to obtain appropriate clinical management for the condition under consideration, which contributed to the clinical worsening of the condition under consideration, during operational service, as a causal result of operational service duties.

[38]14088

the veteran's inability to obtain appropriate clinical management for malignant neoplasm of the endometrium during operational service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[39]14090

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium because of an illness or injury which is identifiable.

14091 — the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related to operational service. [40] [41]

[42]14093

the clinical onset of malignant neoplasm of the endometrium occurred prior to that part of operational service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related.

Clinical worsening and eligible service [14084]

[43]14086

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium during eligible service.

[44]14087

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium during eligible service, as a causal result of eligible service duties.

[45]14089

the veteran's inability to obtain appropriate clinical management for malignant neoplasm of the endometrium during eligible service was due to the veteran's serious default, wilful act or serious breach of discipline.

or

[39]14090

the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium because of an illness or injury which is identifiable.

14092 — the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related to eligible service. [40] [41]

[46]14094

the clinical onset of malignant neoplasm of the endometrium occurred prior to that part of eligible service to which the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related. [47]

Obesity

Malignant neoplasm of the endometrium - Obesity Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Obesity [CR9230]

[48] Medical Report - Obesity [MR9305]

Preliminary questions [14043]

[49]16835

there is some evidence that obesity may be a factor in the development of the condition under consideration.

1169 — the veteran is a woman. [6]

[49]587

the veteran has a history of obesity.

14071 — the veteran has established the causal connection between the obesity and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14072 — the veteran has established the causal connection between the obesity and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14073 — the veteran has established the causal connection between the obesity and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14072]

[50]14074

the obesity was present for at least 10 years before the clinical onset of malignant neoplasm of the endometrium.

[51]591

the obesity was caused by operational service.

or

[52]9004

the veteran has a history of morbid obesity.

[53]28053

the morbid obesity was present for at least 10 years before the clinical onset of malignant neoplasm of the endometrium.

9005 — the morbid obesity is causally related to operational service. [54]

Clinical onset and eligible service [14073]

[55]14075

the obesity was present for at least 20 years before the clinical onset of malignant neoplasm of the endometrium.

[56]3407

the obesity was caused by eligible service.

or

[57]9004

the veteran has a history of morbid obesity.

[53]28054

the morbid obesity was present for at least 20 years before the clinical onset of malignant neoplasm of the endometrium.

9006 — the morbid obesity is causally related to eligible service. [58] [59]

Stein-Leventhal syndrome

Malignant neoplasm of the endometrium - Stein-Leventhal syndrome Factor

Last reviewed for CCPS 30 April 1997.

Preliminary questions [14039]

16832 [60] there is some evidence that Stein-Leventhal syndrome may be a factor in the development of the condition under consideration.

1169 — the veteran is a woman. [6]

[60]14045

the veteran has suffered from Stein-Leventhal syndrome at some time.

14046 [61] the veteran suffered from Stein-Leventhal syndrome before the clinical onset of malignant neoplasm of the endometrium. [62]

14047 — the veteran has established the causal connection between the Stein-Leventhal syndrome and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14050 — the veteran has established the causal connection between the Stein-Leventhal syndrome and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14051 — the veteran has established the causal connection between the Stein-Leventhal syndrome and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14050]

14052 — the Stein-Leventhal syndrome is causally related to operational service. [63] [64]

Clinical onset and eligible service [14051]

14053 — the Stein-Leventhal syndrome is causally related to eligible service. [65] [64]

Treatment with tamoxifen

Malignant neoplasm of the endometrium - Treatment with tamoxifen Factor

Last reviewed for CCPS 30 April 1997.

Preliminary questions [14040]

16833 [66] there is some evidence that treatment with tamoxifen may be a factor in the development of the condition under consideration.

1169 — the veteran is a woman. [6]

[66]14054

the veteran has been treated with tamoxifen at some time.

14056 [67] the treatment with tamoxifen was given for an illness or injury which is identifiable.

14057 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14058 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14059 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14058]

[68]14055

the veteran was treated with tamoxifen for the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium.

14060 — the identified illness or injury for which the treatment with tamoxifen was given is causally related to operational service. [69] [70]

Clinical onset and eligible service [14059]

[71]14107

the veteran was treated with tamoxifen for the identified illness or injury for a period of at least one year before the clinical onset of malignant neoplasm of the endometrium. [72]

14061 — the identified illness or injury for which the treatment with tamoxifen was given is causally related to eligible service. [73] [70]

Source URL (modified on 23/03/2016 - 1:00pm): http://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-endometrium-b045-c541

Links
[1] http://www.rma.gov.au/assets/SOP/2016/011.pdf
[2] http://www.rma.gov.au/assets/SOP/2016/012.pdf
[3] http://clik.dva.gov.au/system/files/media/SOP%20Bulletin%20188.pdf
[4] http://clik.dva.gov.au/user/login?destination=comment/reply/63764%23comment-form
[5] clikpopup://CCPS/A course of therapeutic radiation involving the pelvic organs
[6] clikpopup://CCPS/reject1169No
[7] clikpopup://CCPS/Therapeutic radiation for treatment of identifiable illness
[8] clikpopup://CCPS/reject14063No
[9] clikpopup://CCPS/reject14064No
[10] clikpopup://CCPS/reject14068No
[11] clikpopup://CCPS/reject14068,14069No
[12] clikpopup://CCPS/reject14069No
[13] http://clik.dva.gov.au/node/75169
[14] http://clik.dva.gov.au/nulliparous
[15] http://clik.dva.gov.au/reasons-decision-152
[16] clikpopup://CCPS/reject14096Yes
[17] clikpopup://CCPS/reject14097No
[18] clikpopup://CCPS/reject8870No
[19] clikpopup://CCPS/reject8870,14101No
[20] clikpopup://CCPS/reject14101No
[21] http://clik.dva.gov.au/ccpsmedical-90
[22] clikpopup://CCPS/reject1169Yes
[23] http://clik.dva.gov.au/ccpsg022rc-6
[24] clikpopup://CCPS/HRT consisting of oestrogen unopposed by progesterone at some time
[25] clikpopup://CCPS/reject8813No
[26] clikpopup://CCPS/reject8814No
[27] clikpopup://CCPS/reject14102No
[28] clikpopup://CCPS/reject8823No
[29] clikpopup://CCPS/reject8823,8824No
[30] clikpopup://CCPS/reject8824No
[31] http://clik.dva.gov.au/ccpsother-31
[32] http://clik.dva.gov.au/node/71034
[33] clikpopup://CCPS/Reject/OnsetAfterService
[34] clikpopup://CCPS/Reject/NoPermanentWorsening
[35] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - contributed to worsening
[36] clikpopup://CCPS/ACM/NoContribution
[37] clikpopup://CCPS/ACM/NotOpService
[38] clikpopup://CCPS/ACM/NotOperDuties
[39] clikpopup://CCPS/rejectwilful
[40] clikpopup://CCPS/ACM/NoIllness
[41] clikpopup://CCPS/reject14091,14092No
[42] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - onset prior to operational service
[43] clikpopup://CCPS/ACM/OnsetFailOper
[44] clikpopup://CCPS/ACM/NotEligService
[45] clikpopup://CCPS/ACM/NotEligDuties
[46] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - onset prior to eligible service
[47] clikpopup://CCPS/ACM/OnsetFailElig
[48] http://clik.dva.gov.au/ccpsclaimant-78
[49] http://clik.dva.gov.au/ccpsb045rc-0
[50] clikpopup://CCPS/reject587No
[51] clikpopup://CCPS/reject14074No
[52] clikpopup://CCPS/reject591No
[53] clikpopup://CCPS/reject9004No
[54] clikpopup://CCPS/reject9005No
[55] clikpopup://CCPS/Obesity present for 20 years prior to onset of malignant neoplasm of the endometrium
[56] clikpopup://CCPS/reject14075No
[57] clikpopup://CCPS/reject3407No
[58] clikpopup://CCPS/reject9006No
[59] clikpopup://CCPS/reject9005,9006No
[60] http://clik.dva.gov.au/stein-leventhal-syndrome
[61] clikpopup://CCPS/Stein-Leventhal syndrome present prior to onset of malignant neoplasm of the endometrium
[62] clikpopup://CCPS/reject14046No
[63] clikpopup://CCPS/reject14052No
[64] clikpopup://CCPS/reject14052,14053No
[65] clikpopup://CCPS/reject14053No
[66] http://clik.dva.gov.au/ccpsb009rc-23
[67] clikpopup://CCPS/Tamoxifen for treatment of identifiable illness
[68] clikpopup://CCPS/reject14056No
[69] clikpopup://CCPS/reject14055No
[70] clikpopup://CCPS/reject14060,14061No
[71] clikpopup://CCPS/Took tamoxifen for one year before onset of malignant neoplasm of the endometrium
[72] clikpopup://CCPS/reject14107No
[73] clikpopup://CCPS/reject14061No